Story
Tesla Stock Falls as Q2 Earnings Miss and Margin Pressure Outweigh Revenue Beat
Summary
Tesla reported second-quarter revenue that surpassed expectations, but a significant earnings miss and contracting gross margins sent shares lower as investors assessed the heavy cost of its long-term AI and robotics ambitions.
Tesla Inc. (TSLA) shares fell sharply in pre-market trading after the company reported mixed second-quarter 2026 results, where a strong revenue beat was overshadowed by a larger-than-expected earnings miss and contracting profit margins. The electric vehicle maker's stock was down 7.3% to $346.68 as of Wednesday morning as investors reacted to the firm's aggressive spending plans.
A Mixed Quarterly Report
For the second quarter, Tesla posted revenue of $28.24 billion, exceeding analyst expectations of $25.55 billion by over 10%, as per Investing.com data. However, earnings per share (EPS) came in at $0.33, missing the consensus estimate of $0.49 by nearly 33%.
The post-earnings sell-off pushed the stock toward its 52-week low of approximately $297. The decline from its previous close of $374.01 intensified overnight, signaling growing investor concern over the company's near-term profitability.
Margin Contraction and Spending in Focus
The earnings miss was primarily driven by a significant decline in profitability across key segments. The company's report highlighted the following figures:
Ad- Automotive gross margin (excluding regulatory credits): 16.3%, down from 19.2% in the first quarter.
- Energy gross margin: 20.4%, a steep drop from 39.5% in the prior quarter.
This margin compression comes as Tesla ramps up investment in future growth. The company guided for full-year capital expenditures of more than $25 billion and confirmed it is arranging up to $30 billion in new debt facilities. The spending is targeted at long-horizon projects including the Robotaxi network, the Optimus humanoid robot, and proprietary AI infrastructure.
Analyst Views on Long-Term Bets
Wall Street remains divided on whether the potential payoff from these long-term bets justifies the near-term financial pressure. While Tesla noted its Robotaxi fleet is showing progress with over 380,000 unsupervised miles driven, some analysts urge caution.
Cantor Fitzgerald maintained its "Overweight" rating but trimmed its price target on the stock to $485 from $510. In contrast, Citizens recently initiated coverage with a "Market Perform" rating, calling the Optimus project timeline "too optimistic" given the production complexities. The core challenge for investors is balancing the company's valuation, which prices in flawless execution of its AI ambitions, against the immediate reality of falling margins.
Read next
More on Stocks
Asia and Europe Tipped for Equity Market Leadership Over Next 12 Months
Market analysis suggests Asia ex-Japan offers the highest growth potential, albeit with significant risk, while European equities present a compelling value opportunity as investors look beyond U.S. mega-caps.
aTyr Pharma Shares Surge on FDA Agreement for Pivotal Efzofitimod Trial
Shares of the biopharmaceutical company jumped after it announced an agreement with the U.S. FDA on the design of a Phase 3 study for its lead drug candidate, efzofitimod, in patients with pulmonary sarcoidosis.
Bernstein Taps Amphenol, TE Connectivity as Top Picks for Data Center Growth
Analysts at Bernstein have identified Amphenol and TE Connectivity as leading stocks in the interconnect sector, poised to benefit from the ongoing expansion of data center infrastructure.
AMD Stock Slides From 52-Week High on Summit Disappointment, Analyst Downgrade
Shares of Advanced Micro Devices fell in pre-market trading, pulling back from a recent high as investor hopes for eased U.S.-China tech tensions faded and a recent analyst downgrade cited valuation concerns.